Priyanka Bhateja

KMT2D Mutation Is Associated With Poor Prognosis in Non–Small-Cell Lung Cancer

Fatemeh Ardeshir‐Larijani, Priyanka Bhateja, Mary Beth Lipka et al. · Clinical Lung Cancer · 2018 · 61 citations

Medicine, Genetics, Oncology +8

Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer

Priyanka Bhateja, Gary Wildey, Mary Beth Lipka et al. · Cancer Medicine · 2019 · 57 citations · Full text

Medicine, Genetics, Oncology +13

Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study

Christine H. Chung, Marcelo Bonomi, Conor Steuer et al. · Cancers · 2021 · 57 citations · Full text

Medicine, Oncology, Pharmacology +15

T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma

Xuefeng Wang, Jameel Muzaffar, Kedar Kirtane et al. · Journal for ImmunoTherapy of Cancer · 2022 · 37 citations · Full text

Medicine, Immunology, Oncology +17

Severe late dysphagia and cause of death after concurrent chemoradiation for larynx cancer in patients eligible for RTOG 91-11

Matthew C. Ward, David J. Adelstein, Priyanka Bhateja et al. · Oral Oncology · 2016 · 35 citations

Medicine, Oncology, Radiation Oncology +17